ESR1 and breast cancer: Mechanisms of antiestrogen-resistance in ER+ breast cancer include conversion to ER- by loss of ER expression, mutations in the gene encoding the ER, altered expression of ER transcriptional coregulators, and compensation by other growth/survival pathways [14].